prikaz prve stranice dokumenta Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
  Preuzmi
PDF 3.69 MB
Znanstveni rad - Pregledni rad
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
Cardiovascular Diabetology, 16 (2017); 137. https://doi.org/10.1186/s12933-017-0622-7
Schernthaner, Guntram; Lehmann, Roger; Prázný, Martin; Czupryniak, Leszek; Ducena, Kristine; Fasching, Peter; Janež, Andrej; Karasik, Avraham; Kempler, Peter; Martinka, Emil; Shestakova, Marina V.; Smirčić Duvnjak, Lea; Tankova, Tsvetalina

Citirajte ovaj rad

Schernthaner, G., Lehmann, R., Prázný, M., Czupryniak, L., Ducena, K., Fasching, P. ... Tankova, T. (2017). Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG). Cardiovascular Diabetology, 16., 137. doi: 10.1186/s12933-017-0622-7

Schernthaner, Guntram, et al. "Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)." Cardiovascular Diabetology, vol. 16, 2017, str. 137. https://doi.org/10.1186/s12933-017-0622-7

Schernthaner, Guntram, Roger Lehmann, Martin Prázný, Leszek Czupryniak, Kristine Ducena, Peter Fasching, Andrej Janež, et al. "Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)." Cardiovascular Diabetology 16 (2017): 137. https://doi.org/10.1186/s12933-017-0622-7

Schernthaner, G., et al. (2017) 'Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)', Cardiovascular Diabetology, 16, str. 137. doi: 10.1186/s12933-017-0622-7

Schernthaner G, Lehmann R, Prázný M, Czupryniak L, Ducena K, Fasching P, i sur.. Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG). Cardiovascular Diabetology [Internet]. 23.10.2017. [pristupljeno 19.10.2024.];16:137. doi: 10.1186/s12933-017-0622-7

G. Schernthaner, et al., "Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)", Cardiovascular Diabetology, vol. 16, str. 137, Listopad 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:188201. [Citirano: 19.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:188201
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
AutorGuntram Schernthaner
AutorRoger Lehmann
AutorMartin Prázný
AutorLeszek Czupryniak
AutorKristine Ducena
AutorPeter Fasching
AutorAndrej Janež
AutorAvraham Karasik
AutorPeter Kempler
AutorEmil Martinka
AutorMarina V. Shestakova
AutorLea Smirčić Duvnjak
AutorTsvetalina Tankova
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
AIMS: These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. ----- METHODS: The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method to develop treatment algorithms to aid physicians in the clinical management of patients with T2D at high CV risk. ----- RESULTS: In light of the latest CVOT results, and in particular the EMPA-REG OUTCOME® and LEADER® trials, the diagnosis, assessment, treatment choice and monitoring of patients with T2D and established CVD and/or CKD have been considered together with existing guidelines and presented in two reference algorithms. In addition, adherence, special prescribing considerations and a proposed multidisciplinary management approach have been discussed and are presented with the proposed algorithms. ----- CONCLUSIONS: The latest available high-level evidence on glucose-lowering drugs has enabled CEEDEG to develop practical consensus recommendations for patients with established CVD and/or CKD. These recommendations represent an update to international and country-level guidelines used for these patients, with the aim of providing a resource not only to endocrinologists, but to cardiologists, nephrologists and primary care physicians in the region.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCardiovascular Diabetology
Brojčani podacivol. 16, str. 137
p-ISSN1475-2840
DOIhttps://doi.org/10.1186/s12933-017-0622-7
URN:NBNurn:nbn:hr:105:188201
Datum objave publikacije2017-10-23
URL dokumentahttps://doi.org/10.1186/s12933-017-0622-7
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 09:21:04